Summitry LLC’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.9M Buy
293,212
+49,215
+20% +$3.97M 0.75% 49
2026
Q1
$21.1M Buy
243,997
+241,290
+8,914% +$23.1M 0.75% 53
2025
Q4
$260K Sell
2,707
-46
-2% -$4.47K 0.01% 205
2025
Q3
$262K Buy
2,753
+440
+19% +$40.4K 0.01% 170
2025
Q2
$202K Buy
2,313
+33
+1% +$2.8K 0.01% 170
2025
Q1
$205K Buy
+2,280
New +$204K 0.01% 135
2024
Q4
Sell
-3,503
Closed -$315K 151
2024
Q3
$315K Sell
3,503
-463
-12% -$38.9K 0.02% 103
2024
Q2
$312K Sell
3,966
-375,170
-99% -$30.8M 0.02% 88
2024
Q1
$33M Buy
379,136
+15,831
+4% +$1.35M 1.73% 25
2023
Q4
$29.9M Sell
363,305
-1,026
-0.3% -$78.2K 1.74% 28
2023
Q3
$28.5M Buy
364,331
+7,706
+2% +$645K 1.88% 28
2023
Q2
$31.4M Sell
356,625
-4,290
-1% -$369K 1.98% 24
2023
Q1
$29.1M Sell
360,915
-847
-0.2% -$69K 1.95% 25
2022
Q4
$28.1M Buy
361,762
+2,609
+0.7% +$211K 2.07% 24
2022
Q3
$29M Buy
359,153
+3,649
+1% +$328K 2.19% 22
2022
Q2
$31.9M Sell
355,504
-5,303
-1% -$537K 2.33% 23
2022
Q1
$40M Buy
360,807
+20,184
+6% +$2.13M 2.37% 21
2021
Q4
$35.2M Buy
340,623
+10,863
+3% +$1.26M 2.06% 23
2021
Q3
$41.3M Buy
329,760
+7,771
+2% +$1.01M 2.58% 19
2021
Q2
$40M Buy
321,989
+6,978
+2% +$876K 2.48% 21
2021
Q1
$37.2M Buy
315,011
+10,217
+3% +$1.2M 2.39% 22
2020
Q4
$35.7M Buy
304,794
+1,846
+0.6% +$203K 2.61% 21
2020
Q3
$31.5M Buy
302,948
+24,541
+9% +$2.46M 2.53% 20
2020
Q2
$25.5M Sell
278,407
-2,374
-0.8% -$228K 2.11% 23
2020
Q1
$25.3M Sell
280,781
-859
-0.3% -$91.4K 2.32% 22
2019
Q4
$32M Sell
281,640
-19
-0% -$2.08K 2.57% 22
2019
Q3
$30.6M Sell
281,659
-65,420
-19% -$6.83M 2.41% 21
2019
Q2
$33.8M Sell
347,079
-385
-0.1% -$35.2K 2.78% 18
2019
Q1
$31.6M Sell
347,464
-7,253
-2% -$649K 2.75% 16
2018
Q4
$32.3M Sell
354,717
-11,041
-3% -$1.03M 3.15% 18
2018
Q3
$36M Sell
365,758
-1,632
-0.4% -$151K 3.07% 15
2018
Q2
$31.5M Sell
367,390
-2,149
-0.6% -$179K 2.92% 19
2018
Q1
$29.6M Sell
369,539
-224
-0.1% -$18.5K 2.74% 18
2017
Q4
$29.9M Buy
369,763
+3,567
+1% +$286K 2.71% 19
2017
Q3
$28.5M Buy
366,196
+4,142
+1% +$344K 2.64% 21
2017
Q2
$32.1M Buy
362,054
+5,494
+2% +$463K 3.06% 15
2017
Q1
$28.7M Buy
+356,560
New +$27.9M 2.77% 17
2016
Q4
Sell
-3,897
Closed -$337K 85
2016
Q3
$337K Buy
3,897
+297
+8% +$25.9K 0.03% 71
2016
Q2
$312K Hold
3,600
0.03% 71
2016
Q1
$270K Hold
3,600
0.03% 74
2015
Q4
$277K Hold
3,600
0.03% 65
2015
Q3
$241K Hold
3,600
0.03% 62
2015
Q2
$267K Hold
3,600
0.03% 58
2015
Q1
$281K Hold
3,600
0.03% 56
2014
Q4
$260K Hold
3,600
0.03% 58
2014
Q3
$223K Sell
3,600
-400
-10% -$25.4K 0.03% 62
2014
Q2
$255K Sell
4,000
-2,750
-41% -$167K 0.03% 59
2014
Q1
$415K Sell
6,750
-282,057
-98% -$16.4M 0.05% 50
2013
Q4
$16.6M Sell
288,807
-127,758
-31% -$7.24M 2.18% 24
2013
Q3
$22.2M Sell
416,565
-5,565
-1% -$299K 3.36% 7
2013
Q2
$21.7M Buy
+422,130
New +$20.9M 3.41% 8

Other funds holding MDT

Summitry LLC's MDT Position: Q2 2026 in Review

Summitry LLC increased its Medtronic (MDT) stake by 20% in Q2 2026, buying an estimated $3.97M and bringing the position to 293,212 shares worth $22.9M. The position accounts for 0.75% of the portfolio, ranked #49.

Summitry LLC first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $41.3M in Q3 2021. 2,124 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Summitry LLC held 293,212 shares of Medtronic worth $22.9M as of Q2 2026.
  • Summitry LLC bought 49,215 Medtronic shares in Q2 2026, an estimated $3.97M.
  • Medtronic made up 0.75% of Summitry LLC's portfolio in Q2 2026, its #49 holding.
  • Summitry LLC first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
  • Summitry LLC's Medtronic position peaked at $41.3M in Q3 2021.
  • 2,124 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.